Compugen Ltd
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer (NCT06888921) | Compugen Ltd | 2025-07-21 |
| A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies (NCT06759649) | Compugen Ltd | 2025-01-07 |
| COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies (NCT04354246) | Compugen Ltd | 2020-03-31 |
| COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. (NCT03667716) | Compugen Ltd | 2018-09-06 |
Track Compugen Ltd automatically
Every clearance here is in the API, with alerts when new ones post.